Structure via PubChem · Public domain (PubChem)
AM-2201
Sign in to saveAM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.
Chemical data
- Formula
- C24H22FNO
- Molecular weight
- 359.4 g/mol
- IUPAC name
- [1-(5-fluoropentyl)indol-3-yl]-naphthalen-1-ylmethanone
- SMILES
- C1=CC=C2C(=C1)C=CC=C2C(=O)C3=CN(C4=CC=CC=C43)CCCCCF
- InChIKey
- ALQFAGFPQCBPED-UHFFFAOYSA-N
- XLogP
- 5.9
- Polar surface area
- 22 Ų
- H-bond donors
- 0
- H-bond acceptors
- 2
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Mass
- 359.169
Show 3 more facts
- chemical formula
- C₂₄H₂₂FNO
- canonical SMILES
- C1=CC=C2C(=C1)C=CC=C2C(=O)C3=CN(C4=CC=CC=C43)CCCCCF
- Commons category
- AM-2201
Sources (2)
via Wikidata · CC0
~2 min read
Encyclopedic overview
7 sectionsContents
- Hazards
- Pharmacology
- Pharmacokinetics
- Detection
- Legal status
- See also
- References
AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.
==Hazards== Convulsions have been reported including at doses as low as 10 mg.
Excerpted from Wikipedia’s “AM-2201” article, available under the CC BY-SA 4.0 licence.